Aerin Medical is developing groundbreaking treatments that improve the quality of life for patients suffering from nasal breathing disorders.
Nasal congestion or obstructions collectively account for over 13 million patient visits to physicians’ offices annually in the US alone and affect up to 20% of the global population. Moreover, these disorders result in billions of dollars in direct and indirect costs to healthcare systems combined with a significant burden on quality of life for patients. Despite advances in medical management and surgical interventions, there continues to be a significant void in treatment options for these conditions.
Aerin’s treatments are specifically designed to address nasal congestions and obstruction in the Ear Nose & Throat (ENT) physician’s office, where they can be administered in minutes under the use of a local anesthetic and minimal prep time. Patients can return to normal activity immediately following the procedure. Our non-invasive treatments are designed to effectively bridge the gap between medical therapy and surgical procedures.